PAR 29.3% 26.5¢ paradigm biopharmaceuticals limited..

research reports and media, page-3456

  1. 4,381 Posts.
    lightbulb Created with Sketch. 6924

    Huts,

    They relied on the below 2016 study

    im on my phone (in the back seat travelling through rural NSW - beautiful country side) so can’t do much copying pasting or research (flaky internet at 110km/h, son is driving, not me).


    Link for below:




    http://www.cartrophen.com/wp-content/uploads/2016/07/Pentosan-polysulfate-as-a-disease-modifier-of-cartilage-degeneration-inexperimental-osteoarthritis_Journal-of-Arthrtitis.pdf




    https://hotcopper.com.au/data/attachments/4939/4939790-a2763192720139b86ae927b776e5fd14.jpg
    Last edited by Mozzarc: 02/01/23
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.